CG
ORCL icon

Cynosure Group’s Oracle ORCL Stock Holding History

Cynosure Group’s Portfolio ORCL Stock Details ORCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,847
Closed -$945K – 387
2025
Q4 		$945K Buy
+4,847
New +$1.15M 0.1% 70
2025
Q3 		– Sell
-3,189
Closed -$697K – 385
2025
Q2 		$697K Buy
3,189
+778
+32% +$126K 0.08% 132
2025
Q1 		$337K Buy
2,411
+407
+20% +$66.3K 0.05% 271
2024
Q4 		$334K Sell
2,004
-823
-29% -$146K 0.05% 179
2024
Q3 		$482K Sell
2,827
-497
-15% -$72K 0.07% 164
2024
Q2 		$469K Buy
3,324
+172
+5% +$21.4K 0.08% 149
2024
Q1 		$396K Buy
+3,152
New +$361K 0.07% 144
2020
Q1 		– Sell
-4,181
Closed -$222K – 75
2019
Q4 		$222K Hold
4,181
– – 0.12% 68
2019
Q3 		$230K Sell
4,181
-1,478
-26% -$81.6K 0.13% 67
2019
Q2 		$322K Buy
+5,659
New +$306K 0.15% 66

Other funds holding ORCL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cynosure Group's ORCL Position: Q1 2026 in Review

Cynosure Group sold out of Oracle (ORCL) in Q1 2026, closing a stake of 4,847 shares — an estimated $945K sold.

Cynosure Group first reported a position in ORCL in Q2 2019 and held it in 10 quarters. The position peaked at $945K in Q4 2025. 3,473 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Cynosure Group reported no remaining Oracle position as of Q1 2026 after selling out during the quarter.
  • Cynosure Group sold 4,847 Oracle shares in Q1 2026, an estimated $945K.
  • Cynosure Group first reported a position in Oracle in Q2 2019 and held it in 10 quarters.
  • Cynosure Group's Oracle position peaked at $945K in Q4 2025.
  • 3,473 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.